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Multiple mycotic aneurysms due to Mycobacterium
bovis after intravesical bacillus Calmette-Guérin
therapy
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Mycotic aneurysms are exceptional complications after intravesical instillations of bacillus Calmette-Guérin (BCG) for
bladder carcinoma. We report a patient who underwent an emergency operation for a ruptured carotid aneurysm 16
months after BCG therapy. Postoperative investigations discovered multiple other synchronous aneurysms. Culture of an
abscess surrounding the right carotid artery identifiedMycobacterium bovis varBCG. The patient improved clinically with
antituberculous agents prescribed for 9 months but died from recurrence of bladder carcinoma 16 months later. A
mycotic origin should be evoked when an aneurysm is discovered after BCG therapy. Microbiologic investigation of the
artery wall is diagnostic. ( J Vasc Surg 2009;50:1185-90.)Intravesical instillation of Calmette-Guérin bacillus (ba-
cille bilié de Calmette et Guérin, BCG) is widely used for
treatment of in situ bladder carcinoma and prevention of
superficial bladder tumor recurrences.1-3 Although this treat-
ment is usually well-tolerated, serious complications such as
disseminated granulomatous lesions in various organs have
been reported.4 Vascular complications are exceptional.
CASE REPORT
A 79-year-old man was referred to our hospital in October
2006 because of a painful mass in his neck. His medical history was
significant for superficial bladder carcinoma operated on five times
between 2001 and 2005 using transurethral resection. Adjuvant
intravesical BCG-therapy (Immucyst, Sanofi Pasteur, Lyon,
France) was administered every 6 months between February 2003
and June 2005. He did not take any other medication and had
stopped smoking for 2 years.
The patient complained of a pulsatile and enlarging mass on the
anterior left side of his neck for a year. He denied any compression
symptoms. He also complained of fatigue, poor appetite, and a 4-kg
weight loss 18 months since the completion of the BCG therapy.
The pain started 20 hours before the admission and was associated
with a significant increase of the volume of the cervical mass.
The physical examination showed he was cachectic (body mass
index, 16 kg/m2), afebrile (temperature, 37.2°C), and hemody-
namically stable. A large mass was palpable at the anterolateral side
of the neck. An ecchymosis extending from the neck to the left arm
and the chest was noted. Results of a neurologic examination were
normal. Laboratory tests noted anemia (hemoglobin, 8.5 g/dL)
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doi:10.1016/j.jvs.2009.06.004and inflammatory response syndrome (white cell count 13,500/
L; C-reactive protein, 95 mg/L). Computed tomography (CT)
scan of the head and neck revealed a 50-mm ruptured aneurysm at
the left carotid artery bifurcation. A contralateral 26-mm aneurys-
mal mass was also demonstrated (Fig 1).
Emergency surgery was performed. Left carotid artery bifur-
cation was approached through an incision along the anterior
border of the sternocleidomastoid muscle. Surgical exploration
confirmed the rupture, which appeared to be a pure defect of the
arterial wall. The bifurcation was resected and a common-to-
internal carotid artery bypass with polytetrafluoroethylene (PTFE)
graft was completed. The external carotid artery was ligated.
Pathologic examination confirmed the presence of an aneurysm of
the left carotid bifurcation in an area of calcified and ulcerated
atherosclerotic plaque. There was no granulomatous lesion.
The patient’s postoperative course was unremarkable. We oper-
ated on the contralateral side 10 days after admission and found no
intraoperative evidence of carotid artery aneurysm. The carotid artery
bifurcation was surrounded by an abscess resembling caseum. The
carotid artery was moderately ectatic and inflammatory at this level.
The abscess was drained and the bifurcation was resected. The com-
mon carotid artery was anastomosed end-to-end to the external
carotid artery. The internal carotid artery was directly reimplanted in
the external carotid artery without any graft interposition.
The patient’s postoperative course was uneventful. Pathologic
examination showed necrotizing granulomatous inflammation of
the arterial wall and moderate calcifications of an atherosclerotic
plaque. Bacteriologic examination of the abscess sample showed a
rare acid-fast organism. Polymerase chain reaction (PCR) was
positive for Mycobacterium tuberculosis complex, and culture in
Lowenstein-Jensen medium identified M bovis var. BCG. Results
of multiple sputum and urine cultures were negative for acid-fast
organisms. Results of serology for HIV-1 and HIV-2 were nega-
tive. Echocardiography did not find any valvular vegetation or a
patent foramen ovale.
A postoperative CT scan found four other saccular aneurysms
located on the descending thoracic aorta, the infrarenal aorta, the
left external iliac, and the left posterior tibial arteries (Fig 2). All of
these aneurysms had a diameter of 10 mm and were not consid-
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not reveal any intracranial aneurysm.
The patient was discharged 25 days after admission with
oral antituberculous medications, including isoniazid, etham-
butol and rifampicin for 2 months, followed by isoniazid and
rifampicin for 7 additional months. He improved gradually, but
a recurrence of bladder carcinoma was diagnosed at the 6-
Fig 1. Computed tomography scan of the head and nec
bifurcation (white arrow and [B], black arrows), and (C) a
Fig 2. A postoperative computed tomographic scan rev
artery, (B) the abdominal aorta, and (C and D) the thormonth follow-up, mandating cystectomy. The patient died of bladdercancer progression 16 months after initiation of the antituberculous
therapy. The four remaining aneurysms were stable on the final
follow-up CT scan performed 1 month before the patient died.
DISCUSSION
BCG is a strain of M bovis that has been rendered
ed (A, B) a 50-mm ruptured aneurysm of the left carotid
m mass of the right carotid bifurcation (white arrow).
multiple saccular aneurysms located of (A) the left iliac
orta.k showealedavirulent after being cultured on a beef bile medium for
tation
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tuberculosis since the 1920s and as immunotherapy for
cancer since the mid-1970s. Intravesical administration of
BCG is used as an effective treatment for in situ bladder
carcinoma, recurrent stage Ta disease, and immunoprophy-
laxis after endoscopic resection of stage Ta or T1 disease.1,2
Immucyst is the only available formulation in France, but
five other strains are available commercially (Tice, Con-
naught, RIVM, Tokyo, Danish), with no difference in
preventing tumor progression.3
Treatment protocols include an induction phase with 6
to 12 weekly intravesical instillations, followed by more
spaced out maintenance instillations for 3 to 9 months.1-5
The mechanisms through which BCG acts are unclear,
but induction of a local granulomatous inflammation is
thought to have an effect in killing tumor cells.4 Intra-
vesical BCG instillations are generally considered safe.
According to Lamm et al,5 the most common complica-
tions among 2602 patients were fever (2.9%), hematuria
(1%), infectious granulomatous complications such as
Table. Reported cases of mycotic aneurysms due to Mycob
First author Age Sex
Woods6 62 F
Bornet7 74 M
Deresiewicz8 67 M
Izes9 69 M
Wolf10 80 M
Hellinger11 71 M
Rozenblit12 76 M
Damm13 71 M
LaBerge14 75 M
Seelig15 58 M
Seelig15 71 M
Farber16 74 M
Geldmacher17 68 M
Kamphuis18 65 M
Wada19 75 M
Witjes20 67 M
Dahl21 69 M
Harding22 80 M
Safdar23 79 M
Costiniuk24 75 M
Present case 79 M
Total 72 (58-80)b 20 M
1 F
EA, Extra-anatomic; F, female; IS, in situ; M, male; NS, not specified.
aIncluding the present report, 31 aneurysms in 21 patients were identified i
bMean (range).
cMean follow-up of patients who were alive 1 month after the initial presenprostatitis, and pneumonia, hepatitis, and life-threateningBCG sepsis (1%). No arterial involvement was reported in
their study.
To date, 21 patients (including our patient) were found
to have 31 aneurysms after BCG therapy (Table).6-24 Mean
age at diagnosis was 72 years (range, 58-80 years), and
aneurysms were diagnosed a mean of 23 months (range,
4-69 months) after BCG therapy. Episodes of fever or
fatigue during or immediately after BCG instillations were
reported by 11 patients (52%), but were absent in our
patient. The most frequent clinical symptoms at presenta-
tion were abdominal or back pain in 12 (57%), general
malaise in 11 (52%), fever in 8 (38%), and pulsatile or
painful mass in 4 (19%). The abdominal aorta was involved
in 16 patients (76%), but aneurysms of the aortic arch,9 the
femoral arteries,7,16,19,24 the popliteal artery,15,20 and the
carotid artery17 were also reported. Similar to our patient,
11 patients (52%) presented with rupture, with histologic
finding of arterial wall necrosis in most. Several patients
were immunocompromised at the time of diagnosis be-
ium bovis after bacillus Calmette-Guérin therapya
e from BCG-therapy (mon) Location
17 Infrarenal aorta
26 Left femoral artery
Right femoral artery
14 Infrarenal aorta
Iliac artery
36 Aortic arch
24 Infrarenal aorta
25 Infrarenal aorta
69 Infrarenal aorta
4 Infrarenal aorta
8 Infrarenal aorta
30 Infrarenal aorta
53 Infrarenal aorta
Popliteal pseudoaneurysm
12 Femoral artery
24 Carotid artery
12 Infrarenal aorta
Suprarenal aorta
32 Abdominal aorta
Femoral artery
4 Popliteal artery
18 Infrarenal aorta
24 Infrarenal aorta
11 Infrarenal aorta
24 Infrarenal aorta
Femoral artery
18 Infrarenal aorta
Thoracic aorta
Iliac artery
Posterior tibial artery
Left carotid artery
Right carotid artery
23 (4-69)b 14 unique aneurysms
7 multiple aneurysms
literature since 1975.
.acter
Tim
n thecause of corticosteroid therapy8,9,11,15 or chemotherapy.6
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have participated in the dissemination of the infection.
Assuming the routes of infection are similar to M
tuberculosis, three different mechanisms could explain an
arterial infection by M bovis25:
1. direct intimal colonization during an hematogenous
dissemination, especially in the setting of an altered
arterial wall by atherosclerosis;
2. metastatic implantation of the bacteria through adven-
titial vasa-vasorum, or
3. local vascular extension of an infected site such as con-
tiguous lymphadenitis.
The presence in our patient of multiple aneurysms
without any suspected lymph node involvement supports
the hypothesis of hematogenous dissemination. The smok-
ing history, the occurrence of these aneurysms in typical
atherosclerotic localizations, and the presence of left ca-
rotid artery atherosclerosis at the first surgical procedure
Table. Continued.
Type of surgery Antibiotic therapy Duration (mo
IS prosthesis  NS
IS prosthesis  12
IS vein
EA prosthesis  . . .
Not operated  . . .
IS prosthesis  . . .
IS prosthesis  12
Stent graft  NS
IS prosthesis  NS
EA prosthesis NS NS
IS prosthesis  12
IS prosthesis  12
Popliteal prosthesis removal
IS vein  NS
IS vein  NS
IS prosthesis  . . .
IS prosthesis  . . .
IS prosthesis
Not operated  NS
IS prosthesis  9
IS prosthesis  12
EA prosthesis  12
IS prosthesis  12
IS vein
Not operated
Not operated
Not operated
Not operated
IS prosthesis
Resection-anastomosis
 9
. . . 15/21 9-12 monsuggest a direct intimal invasion. Conversely, an abscesssurrounded the right carotid artery, which could favor the
explanation of a metastatic implantation through the vasa-
vasorum.
Definitive diagnosis of M bovis var. BCG infection is
obtained by culture, which remains the gold standard. It was
positive in all but one reported case.8 Other diagnostic tests
with lower specificity were also reported and include direct
acid-fast bacilli detection,6-12,14,15,17,18,20-24 evidence of
typical caseating granulomatous lesions,6,7,9,13,17-23 and
PCR10,18 from various tissue samples.
The ideal therapeutic management remains controver-
sial. Although 14 patients (71%) were treated with a com-
bination of antituberculous medications and surgical ther-
apy, several were treated with surgery alone,8,10,18,19 and
one popliteal aneurysm completely resolved after antituber-
culous therapy alone.20
No recurrences were noted during follow-up of pa-
tients who received appropriate antibiotic therapy, regard-
less of the surgical repair. Conversely, four of the five
Follow-up Status at last follow-up
11 mon Alive, healthy
18 mon Alive, healthy
Several wk Died disseminated Mycobacterium infection
9 d Died, palliative care
32 mon Alive, aortoenteric fistula at 20 mon
12 mon Alive, healthy
15 mon Died, myocardial infarction
8 mon Alive, healthy
NS . . .
128 mon Alive, healthy
48 mon Alive, healthy
6 mon Alive, healthy
NS —
1 d Died, post-op shock
10 mon Alive, healthy
41 mon Alive, healthy
36 mon Alive, healthy
15 mon Alive, healthy
3 mon Alive, healthy
9 mon Alive, aseptic pseudoaneurysms
16 mon Died, cancer progression
26 (3-128)c mon . . .n)patients who did not receive an antituberculous therapy
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Therefore, therapy with a combination of at least three
antibiotic agents is recommended in all patients for ex-
tended durations of 9 to 12 months. M bovis is naturally
resistant to pyrazinamide, which should not be used.
During surgical repair, resection of all infected arterial
tissues should be considered for large aneurysms. In the
setting of an infected operative field, revascularization with
in situ biologic conduits or extra-anatomic bypasses re-
mains a logical option. Autologous vein grafts7,17,24 and
extra-anatomic14,23 bypasses were successfully performed.
Although never reported, autologous arterial grafts or cryo-
preserved allografts could be used as alternative conduits.
Our review highlights that several in situ prosthetic
conduits6,7,11,13,15,21,22,24 and one stent graft8 were used
without any infectious complication when combined with
antituberculous medications. In our patient, we used an in
situ prosthetic graft for the left carotid artery because the
aneurysm etiology was unknown at the time of the repair.
No infectious recurrence was noted during the 16-month
follow-up. Similar results were reported in the treatment of
mycotic aneurysms due to M tuberculosis.26 These findings
emphasize the need for an experimental evaluation of the
vulnerability of vascular grafts to mycobacterial infection.
Medical management alone could be an option for some
patients. Witjes et al20 reported the complete regression of a
popliteal aneurysm after 4 months of antibiotic therapy; how-
ever, the aneurysm diameter was not stated. Four small aneu-
rysms (diameter 10 mm) in our patient were not resected
and remained stable, but the follow-up duration was limited
by his death at 16 months. Although we cannot provide a clear
therapeutic algorithm due to the limited number of cases, an
antibiotic therapy alone could be an alternative to resection for
small asymptomatic aneurysms.
CONCLUSIONS
Mycotic aneurysm due to M bovis is an exceptional
complication of BCG therapy. This is a life-threatening
complication because rupture is frequent, occurring in
more than half of reported patients and requiring emer-
gency surgical treatment. Small asymptomatic aneurysms
could be managed with antibiotic therapy alone, whereas a
combination of antituberculous therapy and surgical repair
is the treatment of choice for larger aneurysms.
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